NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

0.0%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (86)	3/21/1998 11:41:00 PM
From: Ian@SI	Read Replies (1) of 132

John, Name of the company is QLT Phototherapeutics. A good starting point is the SI thread at: Subject 5265 IR rep is Elayne Wandler who may be contacted at ewandler@qlt-pdt.com if you would like an investor's kit or have other queries. The treatment is a light sensitive drug which is activated by a non thermal laser. AMD drug is called Verteporfin (BPD-MA). Cancer treatment drug is called Photofrin. I believe the treatment is effective for the wet form of AMD (about 2.5M new cases annually in the developed world). Essentially the abnormal capillaries which cause the macular scarring absorb the Verteporfin and then are destroyed by the reaction of the drug with the laser. Treatment needs to be repeated every 3 months. This prevents the scarring of the macula. (Note: Healthcare is not my field of expertise. My description may not be medically precise.) Doing an AltaVista search on either the company or the drug names should produce a variety of interesting sites to view. Good luck, Ian.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next